Screening for loss of heterozygosity and microsatellite instability in oligodendrogliomas

Genes Chromosomes and Cancer

Volumn 21, Issue 3, 1998, Pages 207-216

  Zhu, Jay Jiguang ^a,e   Santarius, Tomás ^a   Wu, Xiaoyun ^b   Tsong, Jerry ^a   Guha, Abhijit ^c   Wu, Julian K ^d   Hudson, Thomas J ^b   Black, Peter McL ^a,f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^c MOUNT SINAI HOSPITAL   (Canada)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MCGILL UNIVERSITY   (Canada)

^f BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GRADING; CANCER SCREENING; CHROMOSOME LOSS; CYTOGENETICS; GENE FREQUENCY; GENETIC STABILITY; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MICROSATELLITE INSTABILITY; OLIGODENDROGLIOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; ALLELES; DNA, NEOPLASM; FEMALE; GENE DELETION; GENETIC SCREENING; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; OLIGODENDROGLIOMA;

MARTES PENNANTI;

EID: 0031929020     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199803)21:3<207::AID-GCC4>3.0.CO;2-3     Document Type: Article

References (47)

1. Baffa R, Negrini M, Mandes B, Rugge M, Ranzani GN, Hirohashi S, Croce CM (1996) Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res 56:268-272.
2. Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestana A, Rey JA (1994a) Molecular analysis of genomic abnormalities in human gliomas. Cancer Genet Cytogenet 73:122-129.
3. Bello MJ, Vaquero J, de Campos JM, Kusak ME, Sarasa JL, Saez-Castresana J, Pestana A, Rey JA (1994b) Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors. Int J Cancer 57:172-175.
4. Buetow KH, Murray JC, Israel JL, London WT, Smith M, Kew M, Blanquet, V, Brechot C, Redcker A, Govindarajah S (1989) Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci USA 86:8852-8856.
5. Carter SL, Negrini M, Baffa R, Gillum DR, Rosenberg AL, Schwartz GF, Croce CM (1994) Loss of heterozygosity at 11q22-q23 in breast cancer. Cancer Res 54:6270-6274.
6. Celli P, Nofrone I, Palma L, Cantore G, Fortuna A (1994) Cerebral oligodendroglioma: prognostic factors and life history. Neurosurgery 35:1018-1034.
7. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
8. Chou D, Miyashita T, Mohrenweiser HW, Ueki K, Kastury K, Druck T, von Deimling A, Huebner K, Reed JC, Louis DN (1996) The BAX gene maps to the glioma candidate region at 19q13.3, but is not altered in human gliomas. Cancer Genet Cytogenet 88:136-140.
9. Coleman A, Robertson G, Lugo TG (1995) Growth control by tumor suppressors in malignant melanoma. Receptor 5:9-19.
10. Dams K, Van de Kelft EJ, Martin JJ, Verlooy J, Willems PJ (1995) Instability of microsatellites in human gliomas. Cancer Res 55:1547-1549.
11. Davis M, Hitchcock A, Foulkes WD, Campbell IG (1996) Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer. Cancer Res 56:741-744.
12. Eubanks PJ, Sawicki MP, Samara GJ, Gatti R, Nakamura Y, Tsao D, Johnson C, Hurwitz M, Wan YJ, Passaro E, Jr. (1994) Putative tumor-suppressor gene on chromosome 11 is important in sporadic endocrine tumor formation. Am J Surg 167:180-185.
13. Frankel RH, Bayona W, Koslow M, Newcomb EW (1992) P53 mutations in human malignant gliomas: Comparison of loss of heterozygosity with mutation frequency. Cancer Res 52:1427-1433.
14. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM (1992) P53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 52:674-679.
15. Hampton GM, Mannermaa A, Winquist R, Alavaikko M, Blanco G, Taskinen, PJ, Kiviniemi H, Newsham I, Cavenee WK, Evans GA (1994a) Loss of heterozygosity in sporadic human breast carcinoma: A common region between 11q22 and 11q23.3. Cancer Res 54:4586-4589.
16. Hampton GM, Penny LA, Baergen RN, Larson A, Brewer C, Liao S, Busby-Earle RM, Williams AW, Steel CM, Bird CC (1994b) Loss of heterozygosity in cervical carcinoma: Subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. Proc Natl Acad Sci USA 91:6953-6957.
17. Herbst RA, Larson A, Weiss J, Cavenee WK, Hampton GM, Arden KC (1995) A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma. Cancer Res 55:2494-2496.
18. Honchel R, Halling KC, Thibodeau SN (1995) Genomic instability in neoplasia. Semin Cell Biol 6:45-52.
19. Hudson TJ, Stein LD, Gerety SS, et al. (1995) An STS-based map of the human genome. Science 270:1945-1954.
20. Jesudasan RA, Rahman RA, Chandrashekharappa S, Evans GA, Srivatsan ES (1995) Deletion and translocation of chromosome 11q13 sequences in cervical carcinoma cell lines. Am J Hum Genet 56:705-715.
21. Jiang X, Hitchcock A, Bryan EJ, Watson RH, Englefield P, Thomas EJ, Campbell IG (1996) Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. Cancer Res 56:3534-3539.
22. Kleihues P, Burger PC, Scheithauer BW (1993) Histological Typing of Tumors of the Central Nervous System, 2nd Ed. New York: Springer-Verlag.
23. Kraus JA, Koopmann J, Kaskel P, Maintz D, Brandner S, Schramm J, Louis DN, Wiestler OD, von Deimling A (1995) Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 54:91-95.
24. Liang BC, Ross DA, Reed E (1995) Genomic copy number changes of DNA repair genes ERCC1 and ERCC2 in human gliomas. J Neurooncol 26:17-23.
25. Looijenga LH, Abraham M, Gillis AJ, Saunders GF, Oosterhuis JW (1994) Testicular germ cell tumors of adults show deletions of chromosomal bands 11p13 and 11p15.5, but no abnormalities within the zinc-finger regions and exons 2 and 6 of the Wilms' tumor 1 gene. Genes Chromosomes Cancer 9:153-160.
26. McGowan-Jordan IJ, Speevak MD, Blakey D, Chevrette M (1994) Suppression of tumorigenicity in human teratocarcinoma cell line PA-1 by introduction of chromosome 4. Cancer Res 54:2568-2572.
27. Ning Y, Weber JL, Killary AM, Ledbetter DH, Smith JR, Pereira-Smith OM (1991) Genetic analysis of indefinite division in human cells: Evidence for a cell senescence-related gene(s) on human chromosome 4. Proc Natl Acad Sci USA 88:5635-5639.
28. Nordenskjold A, Friedman E, Sandstedt B, Soderhall S, Anvret M (1995) Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients. Int J Cancer 63:516-522.
29. Ransom DT, Ritland SR, Kimmel DW, Moertel CA, Dahl RJ, Scheithauer, BW, Kelly PJ, Jenkins RB (1992) Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas. Genes Chromosomes Cancer 5:348-356.
30. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP (1994) Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 145:1175-1190.
31. Ritland SR, Ganju V, Jenkins RB (1995) Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma. Genes Chromosomes Cancer 12:277-282.
32. Seizinger BR, Martuza RL, Gusella JK (1986) Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature 322:644-647.
33. Seizinger BR, Klinger HP, Junien C, Nakamura Y, Le Beau MM, Cavenee W, Emanuel B, Ponder B, Naylor S, Mitelman S, Louis DN, Menon AG, Newsham I, Decker J, Kaelbling M, Henry I, Deimling A (1991) Report of the committee on chromosome and gene loss in human neoplasia. Cytogenet Cell Genet 58:1080-1090.
34. Smith RC, Rukstalis DB (1995) Frequent loss of heterozygosity at 11p loci in testicular cancer. J Urology 153:1684-1687.
35. Speicher MR (1995) Microsatellite instability in human cancer. Oncol Res 7:267-275.
36. Tahara H, Smith AP, Gas RD, Cryns VL, Arnold A (1996) Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas. Cancer Res 56:599-605.
37. Theile M, Hartmann S, Scherthan H, Arnold W, Deppert W, Frege R, Glaab F, Haensch W, Scherneck S (1995) Suppression of tumorigenicity of breast cancer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes. Oncogene 10:439-447.
38. Theile M, Seitz S, Arnold W, Jandrig B, Frege R, Schlag PM, Haensch W, Guski H, Winzer KJ, Barrett JC, Scherneck S (1996) A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer. Oncogene 13:677-685.
39. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, White R (1989) Allelotype of colorectal carcinomas Science 244:207-211.
40. von Deimling A, Eibl RH, Ohgaki H, Louis DN, von Ammon K, Petersen I, Kleihues P, Chung RY, Wiestler OD, Seizinger BR (1992) P53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res 52:2987-2990.
41. Weinberg RA (1991) Tumor suppressor genes. Science 254:1138-1146.
42. Wooster R, Cleton-Jansen AM, Collins N, Mangion J, Cornelis RS, Cooper CS, Gusterson BA, Ponder BA, von Deimling A, Wiestler OD (1994) Instability of short tandem repeats (microsatellites) in human cancers. Nature Genet 6:152-156.
43. Wu JK, Darras BT (1992) Loss of heterozygosity on the short arm of chromosome 17 in human astrocytomas. Neurol Res 14:39-44.
44. Yang-Feng TL, Han H, Chen KC, Li SB, Claus EB, Carcangiu ML, Chambers SK, Chambers JT, Schwartz PE (1993) Allelic loss in ovarian cancer. Int J Cancer 54:546-551.
45. Yong WH, Ueki K, Chou D, Reeves SA, von Deimling A, Gusella JF, Mohrenweiser HW, Buckler AJ, Louis DN (1995) Cloning of a highly conserved human protein serine-threonine phosphatase gene from the glioma candidate region on chromosome 19q13.3. Genomics 29:533-536.
46. Zhu J, Leon SP, Beggs AH, Busque L, Gilliland DG, Black PM (1994) Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. J Clin Endocrinol Metabol 78:922-927.
47. Zhu J, Guo SZ, Beggs AH, Maruyama T, Santarius T, Dashner K, Olsen, N, Wu JK, Black P (1996) Microsatellite instability analysis of primary human brain tumors. Oncogene 12:1417-1423.